Waters New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More Sciex, Waters Partner to Provide Interoperable LC-MS Systems The vendors inked an agreement under which Sciex will offer mass spec instruments that are fully configured and interoperable with Waters UPLC instruments. Waters Posts 31 Percent Increase in Q1 Revenues The revenue growth was driven by increases of sales across all of Waters' major end markets including the pharmaceutical and industrial markets. Waters Enters $500M Senior Notes Private Placement The company sold two series of senior notes totaling $500 million that it said it plans to use to repay outstanding debt and for general corporate purposes. Waters Revenues up 10 Percent in Q4, Down 2 Percent in 2020 Waters' Q4 revenues were $786.7 million, up 10 percent from $716.3 million in Q4 2019, and above the consensus Wall Street estimate of $713.7 million. Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Oct 27, 2020 Waters Q3 Revenues Up 3 Percent Jul 28, 2020 Waters Q2 Revenues Fall 13 Percent, Beat Wall Street Estimate Jul 15, 2020 Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 19, 2020 People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More Jun 12, 2020 2020 ASMS Goes Virtual With Emphasis on Software, Workflow Advances Premium Apr 28, 2020 Waters Q1 Revenues Down 10 Percent Feb 4, 2020 Waters Reports Flat Revenues for Q4, 1 Percent Decline for 2019 Jan 15, 2020 The Decade in Proteomics: Most Significant New Instrumentation Premium Jan 2, 2020 In 2019, Gains in Throughput Position Proteomics for Future Clinical Impact Premium Oct 29, 2019 Waters Q3 Revenues Flat, Fall Short of Expectations Oct 9, 2019 Waters Stock Downgraded by Barclays Sep 30, 2019 Bioanalytical Instrumentation Firm Creoptix Raises CHF 8M Aug 29, 2019 Mass Spec Instrument Advances Are Cause for Optimism in Top-Down Proteomics Premium Jul 30, 2019 Waters Q2 Revenues Flat at $599M Jul 2, 2019 Human Glycome Project Forges Ahead With Support From New England Biolabs, Genos, Waters Premium Jun 7, 2019 ASMS 2019 Sees Slew of New Releases as Vendors Highlight Throughput, Ion Mobility Options Premium May 1, 2019 GenomeWeb Index Sinks in April Amid Wider Biotech Stock Losses Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.